arrow
Back
D

Dae Seog Heo

Seoul National University Hospital

77H-index
662Paper Count
2.3WCitation Count
Published Papers 166
Publication Date
Association between Tumor Size at the Time of Disease Progression and Survival Outcomes
err2024-10-22
err0
errOAAI
errMaeng, Chi Hoon; Kim, Bum Jun; Ahn, Myung-Ju; Choi, In Sil; Zang, Dae Young; Kim, Bo-Hyung; Kwon, Minji; Heo, Dae Seog; Keam, Bhumsuk
errShare
errSave
Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
err2024-09-01
err1
PREAI
errPark, Siyeon; Park, Seongyeol; Kim, Tae Min; Kim, Soyeon; Koh, Jaemoon; Lim, Joonoh; Yi, Kijong; Yi, Boram; Ju, Young Seok; Kim, Miso; Keam, Bhumsuk; Kim, Jung Sun; Jeon, Yoon Kyung; Kim, Dong-Wan; Kim, Young Tae; Heo, Dae Seog
errShare
errSave
The synergistic potential of PARP inhibitors and irinotecan in small cell lung cancer
err2024-03-22
err0
PREAI
errOh, Songji; Kim, Miso; Kim, Soyeon; Keam, Bhumsuk; Youk, Jeonghwan; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog
errShare
errSave
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma (vol 34, pg 2184, 2020)
errLEUKEMIA
IF13.4
err2024-01-10
err0
errOAAI
errLenz, Georg; Hawkes, Eliza; Verhoef, Gregor; Haioun, Corinne; Thye Lim, Soon; Seog Heo, Dae; Ardeshna, Kirit; Chong, Geoffrey; Haaber, Jacob; Shi, Wei; Gorbatchevsky, Igor; Lippert, Susanne; Hiemeyer, Florian; Piraino, Paolo; Beckmann, Georg; Pena, Carol; Buvaylo, Viktoriya; Childs, Barrett H.; Salles, Gilles
errShare
errSave
Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors
err2023-10-01
err0
PREAI
errSang, Y. B.; Kim, Y.; Lee, M. A.; Rha, S. Y.; Jung, M.; Lee, C-K.; Park, Y. H.; Heo, D.; Kim, A.; Kim, J.; Kim, J-H.
errShare
errSave
Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years' real-world experience in a single institute
err2023-04-26
err0
PREAI
errYoon, Jeesun; Kim, Ki Hwan; Kim, Jung Sun; Byun, Ja Min; Hong, Junshik; Shin, Dong-Yeop; Koh, Youngil; Kim, Tae Min; Kim, Inho; Yoon, Sung-Soo; Heo, Dae Seog; Park, Hyunkyung; Park, Jin Hyun
errShare
errSave
Treatment-free remission after discontinuation of ALK tyrosine kinase inhibitors (TKIs) in patients with ALK-positive anaplastic large cell lymphoma (ALCL)
err2023-04-04
err0
PREAI
errKim, Jinyong; Kim, Soyeon; Kim, Tae Min; Youk, Jeonghwan; Kim, Miso; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog
errShare
errSave
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
err2022-07-22
err3
errOAAI
errPark, Ha-Ram; Kim, Seong-Eun; Keam, Bhumsuk; Chung, Hyewon; Seok, Seung Hyeok; Kim, Soyeon; Kim, Miso; Kim, Tae Min; Doh, Junsang; Kim, Dong-Wan; Heo, Dae Seog
errShare
errSave
Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab
errCHEST
IF8.6
err2022-05-01
err26
errOAAI
errPark, Jun Won; Curtis, Jeffrey R.; Jun, Kang Il; Kim, Tae Min; Heo, Dae Seog; Ha, Jongwon; Suh, Kyung-Suk; Lee, Kwang-Woong; Lee, Hajeong; Yang, Jaeseok; Kim, Min Jung; Choi, Yunhee; Lee, Eun Bong
errShare
errSave
Hospice-Palliative Medicine as a Model of Value-Based Healthcare
err2022-01-01
err3
errOAAI
errHeo, Dae Seog; Yoo, Shin Hye; Keam, Bhumsuk; Yoo, Keunjoo; Choi, Insun; Kim, Min-Jeong
errShare
errSave
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
err2021-10-05
err86
errOAAI
errOh, So Yeon; Kim, Soyeon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog
errShare
errSave
A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas
err2021-04-01
err17
errOAAI
errKim, Miso; Lee, Jeong-Ok; Koh, Jiwon; Kim, Tae Min; Lee, Ji Yun; Jeon, Yoon Kyung; Keam, Bhumsuk; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog
errShare
errSave
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma
err2021-02-01
err14
errOAAI
errKang, Minsu; Park, Changhee; Kim, Se Hyun; Yoon, Sock Won; Suh, Koung Jin; Kim, Yu Jung; Ock, Chan-Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok
errShare
errSave
Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients
err2021-01-28
err25
errOAAI
errHeo, Ja Yoon; Yoo, Shin Hye; Suh, Koung Jin; Kim, Se Hyun; Kim, Yu Jung; Ock, Chan-Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok
errShare
errSave
Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells
err2020-12-01
err12
errOAAI
errPark, Siyeon; Kim, Tae Min; Cho, Sung-Yup; Kim, Soyeon; Oh, Yumi; Kim, Miso; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog
errShare
errSave
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
err2020-08-23
err56
errOAAI
errPark, Ji-Eun; Kim, Seong-Eun; Keam, Bhumsuk; Park, Ha-Ram; Kim, Soyeon; Kim, Miso; Kim, Tae Min; Doh, Junsang; Kim, Dong-Wan; Heo, Dae Seog
errShare
errSave
Clinical Application of Next-Generation Sequencing-Based Panel to BRAF Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies
err2020-03-02
err15
PREAI
errPark, Changhee; Kim, Miso; Kim, Min Jung; Kim, Hyeongmin; Ock, Chan-Young; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Kim, Jong-Il; Heo, Dae Seog
errShare
errSave